Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.VolitionRx Limited (VNRX) Q3 2026 Earnings Call Transcript
VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
VolitionRX (NYSEAMERICAN:VNRX) Stock Breaks Below 50 Day Moving Average – What’s Next?
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
VolitionRx Participates in Launch of DETECSEPS Program in France
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
VolitionRX (NYSEAMERICAN:VNRX) Share Price Crosses Below Fifty Day Moving Average – Here’s Why
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
VolitionRx Limited (VNRX) Q2 2026 Earnings Call Transcript
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
Volition Advances Nu.Q® NETs Platform Towards Commercialization